Please use this identifier to cite or link to this item:
https://hdl.handle.net/10216/80637Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.creator | Lucilia Saraiva | |
| dc.date.accessioned | 2022-09-12T05:02:16Z | - |
| dc.date.available | 2022-09-12T05:02:16Z | - |
| dc.date.issued | 2014 | |
| dc.identifier.other | sigarra:44950 | |
| dc.identifier.uri | https://hdl.handle.net/10216/80637 | - |
| dc.description.abstract | The present application discloses novel family of Tryptophanol-Derived Oxazoloisoindolinones for use in the treatment of p53 associated conditions, such as cancer. These compounds are p53 activators and may be used in pharmaceutical compositions, alone or in combination with other chemoterapeutic agents. | |
| dc.language.iso | eng | |
| dc.relation | info:eu-repo/grantAgreement/FCT - Fundação para a Ciência e Tecnologia/Operacional Factores de Competitividade/PTDC/SAU-FAR/110848/2009/Estudos funcionais, moleculares e farmacológicos das proteínas da família p53: da levedura às células humanas/Família P53 | |
| dc.rights | openAccess | |
| dc.rights.uri | https://creativecommons.org/licenses/by-nc/4.0/ | |
| dc.subject | Ciências da Saúde, Ciências médicas e da saúde | |
| dc.subject | Health sciences, Medical and Health sciences | |
| dc.title | TRYPTOPHANOL-DERIVED OXAZOLOISOINDOLINONES: SMALL-MOLECULE P53 ACTIVATORS | |
| dc.type | Patente | |
| dc.contributor.uporto | Faculdade de Farmácia | |
| dc.subject.fos | Ciências médicas e da saúde | |
| dc.subject.fos | Medical and Health sciences | |
| Appears in Collections: | FFUP - Patente | |
This item is licensed under a Creative Commons License
